Literature DB >> 26272791

CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration.

Larissa Shamseer1, Margaret Sampson2, Cecilia Bukutu3, Christopher H Schmid4, Jane Nikles5, Robyn Tate6, Bradley C Johnston7, Deborah Zucker8, William R Shadish9, Richard Kravitz10, Gordon Guyatt11, Douglas G Altman12, David Moher1, Sunita Vohra13.   

Abstract

N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26272791     DOI: 10.1016/j.jclinepi.2015.05.018

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

Review 1.  Recent highlights of Chinese medicine for advanced lung cancer.

Authors:  Xi-Ran He; Shu-Yan Han; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

Review 2.  Personalized (N-of-1) Trials for Depression: A Systematic Review.

Authors:  Ian M Kronish; Meghan Hampsey; Louise Falzon; Beatrice Konrad; Karina W Davidson
Journal:  J Clin Psychopharmacol       Date:  2018-06       Impact factor: 3.153

3.  Causal Analysis of Self-tracked Time Series Data Using a Counterfactual Framework for N-of-1 Trials.

Authors:  Eric J Daza
Journal:  Methods Inf Med       Date:  2018-04-05       Impact factor: 2.176

4.  Exercise and Physical Therapy Interventions for Children with Ataxia: A Systematic Review.

Authors:  Helen Hartley; Elizabeth Cassidy; Lisa Bunn; Ram Kumar; Barry Pizer; Steven Lane; Bernie Carter
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

Review 5.  Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review.

Authors:  Simon L Turner; Amalia Karahalios; Andrew B Forbes; Monica Taljaard; Jeremy M Grimshaw; Allen C Cheng; Lisa Bero; Joanne E McKenzie
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

Review 6.  Making the switch: From case studies to N-of-1 trials.

Authors:  Amanda Margolis; Christopher Giuliano
Journal:  Epilepsy Behav Rep       Date:  2019-10-25

7.  Randomized Single-Case Experimental Designs in Healthcare Research: What, Why, and How?

Authors:  René Tanious; Patrick Onghena
Journal:  Healthcare (Basel)       Date:  2019-11-13

Review 8.  Developments in evidence creation for treatments of inborn errors of metabolism.

Authors:  Sylvia Stockler-Ipsiroglu; Beth K Potter; Nataliya Yuskiv; Kylie Tingley; Marc Patterson; Clara van Karnebeek
Journal:  J Inherit Metab Dis       Date:  2020-10-04       Impact factor: 4.982

Review 9.  Motor Performance in Male Youth Soccer Players: A Systematic Review of Longitudinal Studies.

Authors:  Maryam Abarghoueinejad; Adam D G Baxter-Jones; Thayse Natacha Gomes; Daniel Barreira; José Maia
Journal:  Sports (Basel)       Date:  2021-04-19

10.  Individualized Chinese medicine for the treatment of diabetic patients with dry eye disease: A single-case randomized controlled protocol.

Authors:  Ruibao Liu; Ying Zhao; Yanxia Wu; Minglu Guo; Yu Duan; Jianbin Ye; Xuejing Lu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.